Almoosa Health Co (SAU:4018) EBIT: ﷼238 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4018 Almoosa Health Co SAU:4018
14 GF Score
Price ﷼118.30
! 5 Warning Signs
View Full Analysis

What is Almoosa Health Co EBIT?

Almoosa Health Co SAU:4018 +0.25% 14 EBIT is ﷼238 Mil as of Mar. 2026. GuruFocus rates SAU:4018 with a GF Score™ of 14/100. The stock has 5 warning signs investors should review.

Almoosa Health Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ﷼28 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ﷼238 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Almoosa Health Co's annualized ROC % for the quarter that ended in Mar. 2026 was 4.38%. Almoosa Health Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.96%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Almoosa Health Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 3.89%.

Almoosa Health Co  (SAU:4018) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Almoosa Health Co's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=141.112 * ( 1 - 4.69% )/( (2942.188 + 3192.541)/ 2 )
=134.4938472/3067.3645
=4.38 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3313.101 - 290.358 - ( 80.555 - max(0, 464.171 - 799.513+80.555))
=2942.188

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3589.154 - 321.088 - ( 75.525 - max(0, 520.989 - 891.499+75.525))
=3192.541

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Almoosa Health Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=113.596/( ( (2452.339 + max(324.332, 0)) + (2635.316 + max(331.096, 0)) )/ 2 )
=113.596/( ( 2776.671 + 2966.412 )/ 2 )
=113.596/2871.5415
=3.96 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(615.077 + 78.21 + 25.067) - (290.358 + 0 + 103.664)
=324.332

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(690.839 + 83.423 + 40.822) - (321.088 + 0 + 162.9)
=331.096

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Almoosa Health Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=238.441/6136.086
=3.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almoosa Health Co EBIT Related Terms

Almoosa Health Co EBIT Historical Data

* Premium members only.

The historical data trend for Almoosa Health Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almoosa Health Co EBIT Chart

Almoosa Health Co Annual Data
Trend Dec23 Dec24 Dec25
EBIT
0.00 143.11 264.75

Almoosa Health Co Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.80 56.53 58.51 95.00 28.40

SAU:4018 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Almoosa Health Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Almoosa Health Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Almoosa Health Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Almoosa Health Co's EV-to-EBIT falls into.


SAU:4018
14GF Score
Almoosa Health Co SAU:4018
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Almoosa Health Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼238 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ﷼238 Mil mean?
Almoosa Health Co (SAU:4018) has a EBIT of ﷼238 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Almoosa Health Co.
Is Almoosa Health Co's EBIT too high?
Almoosa Health Co's current EBIT is ﷼238 Mil. Overall, Almoosa Health Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Almoosa Health Co's EBIT compare to HCA and THC?
Almoosa Health Co's EBIT of ﷼238 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Almoosa Health Co. Almoosa Health Co's current EBIT is ﷼238 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almoosa Health Co stock overvalued right now?
Almoosa Health Co (SAU:4018) has a current EBIT of ﷼238 Mil. The current EBIT is ﷼238 Mil. Almoosa Health Co's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Almoosa Health Co (SAU:4018), the current EBIT is ﷼238 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Almoosa Health Co Business Description

Address 3256 Dahran Street, P.O. Box 5098, Alkhars district, Al Mubarraz, SAU, 31982
Almoosa Health Co provides integrated healthcare services that include primary, acute and rehabilitative care along with ancillary services such as pharmaceuticals, home healthcare and telemedicine. The company is also designing, constructing and developing hospitals care centers. The reported segments are: Medical Services and Hospital: Focused on delivering medical care and treatment; Rehabilitation Centre: Specializing in rehabilitation-related services; Pharmacy: Engaged in the sale of medicines.
14GF Score

Get the complete analysis for SAU:4018

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼118.30
Price